A team from the Pennsylvania Biotechnology Center (PABC) and B+Labs dove into BIO International, networking with industry leaders, government officials and other important participants at what organizers say is “the largest and most comprehensive event for biotechnology.”
The convention was held this year in Boston June 16-19 and attracted more than 22,000 professionals from around the globe.
Gov. Josh Shapiro with Nick Spring, PABC’s entrepreneur in residence
Led by CEO Lou Kassa, who spoke on two panels, the PABC and B+Labs teams conducted numerous prescheduled small group and one-on-one meetings, attended multiple conference sessions and had many impromptu conversations, often at the Pennsylvania Pavilion. The PABC was among the Pavilion’s sponsors, where Gov. Shapiro and other top officials spent some time.
Along with Kassa, the PABC team comprised Bob Christmas, Alaina Schukraft and Nick Spring. B+labs was represented by Matthew Burkhardt, Bob Rovinsky and Brandywine Realty Trust Vice President Jeff DeVuono.
The Pennsylvania Biotechnology Center (PABC): Nearly 100 companies belong to the PABC, which is a nonprofit life sciences incubator and accelerator providing a collaborative ecosystem and state-of-the-art laboratory and office space. There are nearly 70 early-stage biotech companies onsite at the PABC’s two locations. Along with its campus in Doylestown, where a new building with labs and offices opened two years ago, the PABC operates B+labs at Cira Centre in University City, Philadelphia. B+labs, which was launched in 2022, is a partnership with Brandywine Realty Trust. The PABC uses a highly successful services-based approach to nurture and guide its member companies to success, advancing biotechnology, maximizing synergies among nonprofit scientists and their commercial colleagues, and launching new ideas and discoveries. PABC companies account for 17% of all National Institutes of Health SBIR grants awarded in Pennsylvania and over the years have created billions of dollars in market value from IPOs, acquisitions and commercial valuations.
A team from the Pennsylvania Biotechnology Center (PABC) and B+Labs dove into BIO International, networking with industry leaders, government officials and other important participants at what organizers say is “the largest and most comprehensive event for biotechnology.”
The convention was held this year in Boston June 16-19 and attracted more than 22,000 professionals from around the globe.
Led by CEO Lou Kassa, who spoke on two panels, the PABC and B+Labs teams conducted numerous prescheduled small group and one-on-one meetings, attended multiple conference sessions and had many impromptu conversations, often at the Pennsylvania Pavilion. The PABC was among the Pavilion’s sponsors, where Gov. Shapiro and other top officials spent some time.
Along with Kassa, the PABC team comprised Bob Christmas, Alaina Schukraft and Nick Spring. B+labs was represented by Matthew Burkhardt, Bob Rovinsky and Brandywine Realty Trust Vice President Jeff DeVuono.
The Pennsylvania Biotechnology Center (PABC): Nearly 100 companies belong to the PABC, which is a nonprofit life sciences incubator and accelerator providing a collaborative ecosystem and state-of-the-art laboratory and office space. There are nearly 70 early-stage biotech companies onsite at the PABC’s two locations. Along with its campus in Doylestown, where a new building with labs and offices opened two years ago, the PABC operates B+labs at Cira Centre in University City, Philadelphia. B+labs, which was launched in 2022, is a partnership with Brandywine Realty Trust. The PABC uses a highly successful services-based approach to nurture and guide its member companies to success, advancing biotechnology, maximizing synergies among nonprofit scientists and their commercial colleagues, and launching new ideas and discoveries. PABC companies account for 17% of all National Institutes of Health SBIR grants awarded in Pennsylvania and over the years have created billions of dollars in market value from IPOs, acquisitions and commercial valuations.